A Phase 1, Single Dose Bioequivalence And Food Effect Study In Healthy Volunteers Comparing The Commercial Image Capsules To The Immediate Release Tablets And Powder In Capsule Formulations Of Crizotinib (PF-02341066), And The Commercial Image Capsule In The Fasted To Fed State.
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Crizotinib (Primary)
- Indications Cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- 30 Nov 2010 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
- 30 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2010 Planned end date changed from 1 Oct 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History